Acute exacerbations in COPD patients are associated with increased levels of hyaluronic acid and heparan sulfate in BAL

E. Papakonstantinou, I. Klagas, S. Batzios, M. Roth, M. Tamm, D. Stolz (Basel, Switzerland; Thessaloniki, Greece)

Source: International Congress 2014 – Translational studies in COPD
Session: Translational studies in COPD
Session type: Thematic Poster Session
Number: 843
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Papakonstantinou, I. Klagas, S. Batzios, M. Roth, M. Tamm, D. Stolz (Basel, Switzerland; Thessaloniki, Greece). Acute exacerbations in COPD patients are associated with increased levels of hyaluronic acid and heparan sulfate in BAL. Eur Respir J 2014; 44: Suppl. 58, 843

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Activation of MMP-9 in BAL is increased in COPD exacerbation independently of smoking, lung function, microbiology and treatment
Source: International Congress 2014 – New studies into pulmonary proteases and antiproteases
Year: 2014

Glycosaminoglycans significantly correlate with matrix metalloproteinases during exacerbations of COPD
Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Year: 2015

Pulmonary and systemic inflammation in patients with AECOPD
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013

Cellular composition of bronchoalveolar lavage (BAL) as inflammation indicator in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – Diagnostic and therapeutic bronchoscopy: old and new techniques for interventional pulmonology
Year: 2014


Altered expression of glycosaminoglycans in the BAL of COPD patients with acute exacerbation
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013

Changes of IL-6 level in bronchoalveolar fluid in patients with acute exacerbation of COPD before and after the treatment with tiotropium bromide, and its significance
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013

Changes of TNF-a level in bronchoalveolar fluid of patients with chronic obstructive pulmonary disease before and after the 30 days treatment with tiotropium bromide
Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects
Year: 2015

Diagnostic implications of sTREM-1 in induced sputum and BAL fluid of patients with asthma and COPD
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015

Profiling the proteome of the lower airway respiratory tract lining fluid in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Biomarkers in asthma and COPD
Year: 2013


HNP and CCSP protein levels are differentially regulated in BAL from patients with obstructive and restrictive chronic allograft dysfunctions
Source: International Congress 2015 – Predictors of lung transplant complications
Year: 2015

Lung microbiome is associated with asthma severity in fungal associated asthma
Source: International Congress 2015 – Phenotyping asthma with biomarkers
Year: 2015


The dynamics of IV-type collagen contens in balf of patients with chronic bronchitis and chronic bronchitis complicated with secondary bronchiectasis
Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases
Year: 2013

Surfactant protein D and its oligomeric forms in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013


Expression of matrix metalloproteinases in bronchoalveolar cells in COPD and in COPD phenotypes
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015


Differential bronchoalveolar expression of candidate microRNAs in chronic obstructive pulmonary disease, asthma bronchiale and pulmonary sarcoidosis
Source: International Congress 2014 – Novel epigenetic regulators for targeting via nanomedicine
Year: 2014

Chemokine concentrations in bronchoalveolar lavage (BAL) in asthma and eosinophilic bronchitis
Source: Annual Congress 2004 - Immunology of airway and pulmonary disease
Year: 2004


Activity of neutrophils in bronchoalveolar lavage fluid in children with chronic bronchiolitis and asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 272s
Year: 2001

Targeting PI3KΔ or JAK in T-cells from COPD and severe asthma subjects reduces corticosteroid insensitive inflammatory responses
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013

Lipid mediator levels evidence gender-specific increases in bronchoalveolar lavage fluid of COPD patients relative to healthy smokers
Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making
Year: 2013

Elevated Tryptase concentration In bronchoalveolar lavage fluid from patients with chronic eosinophilic pneumonia
Source: International Congress 2014 – Biomarkers of asthma and clinical immunology
Year: 2014